# Relative Contribution of Brain Insulin Action for Postprandial Metabolism

> **NCT06295640** · NA · ACTIVE_NOT_RECRUITING · sponsor: **University of Ulm** · enrollment: 31 (actual)

## Conditions studied

- Glucose Metabolism Disorders

## Interventions

- **OTHER:** Oral glucose tolerance test with double-tracer dilution and intranasal insulin spray
- **OTHER:** Oral glucose tolerance test with double-tracer dilution and intranasal placebo spray

## Key facts

- **NCT ID:** NCT06295640
- **Lead sponsor:** University of Ulm
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-03-18
- **Primary completion:** 2025-09-05
- **Final completion:** 2026-06
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2026-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06295640

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06295640, "Relative Contribution of Brain Insulin Action for Postprandial Metabolism". Retrieved via AI Analytics 2026-08-01 from https://api.ai-analytics.org/clinical/NCT06295640. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*